Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Hindustan Unilever Limited (HINDUNILVR.NS)
Mumbai, IN
Hindustan Unilever Limited operates as a prominent consumer goods entity, manufacturing and distributing a diverse portfolio of home care, personal care, food, and refreshment items. Its market reach extends throughout India and into global territories. The company's business activities are structured into distinct segments. The Home Care division supplies essentials such as detergent bars, powders, and liquids, scourers, and is also involved in water treatment and purification systems. The Beauty & Personal Care segment offers products for oral, skin, and hair hygiene, alongside soaps, deodorants, talcum powder, color cosmetics, and salon services. Within the Foods & Refreshment segment, consumers find culinary products like tomato and fruit-based items and soups, as well as beverages such as tea and coffee, health-focused drinks, ice creams, and frozen desserts. An "Others" segment manages export operations and consignment sales. Furthermore, the company holds interests in beauty salons, contract manufacturing (job work), discharge trusts, and real estate. Founded in 1888, the organization is headquartered in Mumbai, India, and functions as a subsidiary of Unilever Plc.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.07% | -2.14% | +4.88% | -6.19% | -6.76% | -2.39% | -5.12% | -13.83% | -2.94% | +165.01% | +3,557.18% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 9 | -1 |
| Buy | 15 | -1 |
| Hold | 9 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 2 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+2.5% Q1'26: +4.3% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%+41.2% ★ Q1'26: +21.3% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+16.9% Q1'26: +34.6% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+21.3% ★ Q1'26: +21.4% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+24.6% ★ Q1'26: +24.9% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+0.0% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×0.10× Q1'26: 0.10× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 18 Rev. Ana. 14 EPS Ana. |
Mar 2027 21 Rev. Ana. 17 EPS Ana. |
Mar 2028 20 Rev. Ana. 18 EPS Ana. |
Mar 2029 10 Rev. Ana. 8 EPS Ana. |
Mar 2030 5 Rev. Ana. 3 EPS Ana. |
Mar 2031 4 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
199.92B
est: 196.98B (+1.5%)
|
233.22B
est: 231.93B (+0.6%)
|
268.24B
est: 267.48B (+0.3%)
|
290.19B
est: 292.90B (-0.9%)
|
317.12B
est: 306.89B (+3.3%)
|
321.86B
est: 325.74B (-1.2%)
|
331.62B
est: 328.06B (+1.1%)
|
353.73B
est: 354.81B (-0.3%)
|
391.37B
est: 389.75B (+0.4%)
|
396.12B
est: 403.72B (-1.9%)
|
469.20B
est: 457.70B (+2.5%)
|
523.06B
est: 511.80B (+2.2%)
|
604.01B
est: 596.51B (+1.3%)
|
617.25B
est: 611.50B (+0.9%)
|
628.81B
est: 619.55B (+1.5%)
|
643.71B
627.69B – 657.23B
+3.9% YoY
|
697.56B
675.91B – 729.92B
+8.4% YoY
|
754.62B
735.68B – 813.50B
+8.2% YoY
|
814.75B
812.70B – 816.79B
+8.0% YoY
|
862.98B
838.86B – 917.22B
+5.9% YoY
|
945.24B
918.82B – 1.00T
+9.5% YoY
|
| EBITDA |
29.66B
est: 33.94B (-12.6%)
|
38.57B
est: 43.30B (-10.9%)
|
53.18B
est: 47.30B (+12.4%)
|
55.14B
est: 63.38B (-13.0%)
|
66.43B
est: 66.87B (-0.7%)
|
63.95B
est: 74.40B (-14.0%)
|
69.25B
est: 68.09B (+1.7%)
|
78.24B
est: 78.68B (-0.6%)
|
91.73B
est: 90.48B (+1.4%)
|
102.58B
est: 99.88B (+2.7%)
|
117.68B
est: 118.42B (-0.6%)
|
130.47B
est: 132.59B (-1.6%)
|
145.71B
est: 148.49B (-1.9%)
|
152.56B
est: 162.44B (-6.1%)
|
159.08B
est: 151.35B (+5.1%)
|
157.62B
153.70B – 160.93B
+4.1% YoY
|
170.81B
165.51B – 178.73B
+8.4% YoY
|
184.78B
180.14B – 199.20B
+8.2% YoY
|
199.50B
199.00B – 200.00B
+8.0% YoY
|
211.32B
205.41B – 224.60B
+5.9% YoY
|
231.46B
224.99B – 246.00B
+9.5% YoY
|
| EBIT |
27.37B
est: 26.28B (+4.2%)
|
36.23B
est: 25.36B (+42.9%)
|
50.67B
est: 37.46B (+35.3%)
|
52.19B
est: 42.80B (+21.9%)
|
63.21B
est: 49.68B (+27.2%)
|
60.42B
est: 54.59B (+10.7%)
|
64.93B
est: 56.01B (+15.9%)
|
73.04B
est: 64.99B (+12.4%)
|
86.08B
est: 76.57B (+12.4%)
|
92.56B
est: 83.20B (+11.3%)
|
106.94B
est: 95.25B (+12.3%)
|
119.56B
est: 106.65B (+12.1%)
|
134.34B
est: 119.44B (+12.5%)
|
140.40B
est: 130.66B (+7.5%)
|
145.53B
est: 138.79B (+4.9%)
|
144.54B
140.94B – 147.58B
+4.1% YoY
|
156.63B
151.77B – 163.90B
+8.4% YoY
|
169.45B
165.19B – 182.67B
+8.2% YoY
|
182.95B
182.49B – 183.41B
+8.0% YoY
|
193.78B
188.36B – 205.96B
+5.9% YoY
|
212.25B
206.32B – 225.59B
+9.5% YoY
|
| Net Income |
23.07B
est: 23.70B (-2.7%)
|
27.91B
est: 27.04B (+3.2%)
|
38.29B
est: 32.18B (+19.0%)
|
39.46B
est: 41.67B (-5.3%)
|
43.63B
est: 43.56B (+0.2%)
|
40.82B
est: 45.30B (-9.9%)
|
44.76B
est: 41.57B (+7.7%)
|
52.14B
est: 48.64B (+7.2%)
|
60.54B
est: 57.59B (+5.1%)
|
67.48B
est: 62.28B (+8.3%)
|
79.95B
est: 74.63B (+7.1%)
|
88.79B
est: 83.56B (+6.3%)
|
101.20B
est: 93.58B (+8.1%)
|
102.77B
est: 102.37B (+0.4%)
|
106.49B
est: 103.19B (+3.2%)
|
106.33B
102.95B – 109.07B
+3.0% YoY
|
112.94B
109.56B – 122.25B
+6.2% YoY
|
125.36B
119.87B – 134.91B
+11.0% YoY
|
137.19B
132.57B – 146.54B
+9.4% YoY
|
141.00B
135.88B – 152.52B
+2.8% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
51.09B
est: 55.85B (-8.5%)
|
51.70B
est: 69.55B (-25.7%)
|
27.65B
est: 71.53B (-61.3%)
|
30.83B
est: 51.09B (-39.7%)
|
76.29B
est: 57.86B (+31.9%)
|
77.22B
est: 84.47B (-8.6%)
|
78.96B
est: 79.18B (-0.3%)
|
84.94B
est: 84.70B (+0.3%)
|
91.64B
est: 99.50B (-7.9%)
|
66.52B
est: 98.08B (-32.2%)
|
72.29B
est: 99.92B (-27.7%)
|
73.90B
est: 111.88B (-33.9%)
|
78.64B
est: 125.29B (-37.2%)
|
96.12B
est: 137.06B (-29.9%)
|
93.63B
est: 99.16B (-5.6%)
|
103.27B
100.70B – 105.44B
+4.1% YoY
|
111.91B
108.44B – 117.10B
+8.4% YoY
|
121.07B
118.03B – 130.51B
+8.2% YoY
|
130.71B
130.39B – 131.04B
+8.0% YoY
|
138.45B
134.58B – 147.15B
+5.9% YoY
|
151.65B
147.41B – 161.18B
+9.5% YoY
|
| EPS |
10.53
est: 10.14 (+3.9%)
|
12.92
est: 12.09 (+6.9%)
|
17.71
est: 15.44 (+14.7%)
|
18.24
est: 17.17 (+6.2%)
|
20.17
est: 18.53 (+8.9%)
|
19.13
est: 18.89 (+1.2%)
|
20.68
est: 19.56 (+5.7%)
|
24.09
est: 23.72 (+1.5%)
|
27.97
est: 28.57 (-2.1%)
|
31.17
est: 32.67 (-4.6%)
|
34.03
est: 34.25 (-0.6%)
|
37.79
est: 37.66 (+0.4%)
|
43.07
est: 42.33 (+1.7%)
|
43.74
est: 43.67 (+0.2%)
|
45.32
est: 43.53 (+4.1%)
|
44.96
43.81 – 46.41
+3.3% YoY
|
48.41
46.62 – 52.02
+7.7% YoY
|
53.59
51.01 – 57.41
+10.7% YoY
|
58.82
56.41 – 62.36
+9.8% YoY
|
60.00
57.82 – 64.90
+2.0% YoY
|
—
— – —
-100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-05 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-04 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Priya Nair | Chief Executive Officer, MD & Director | 224M | female |
| Bittianda Ponnappa Biddappa | Chief People, Transformation and Sustainability Officer & Executive Director | 97M | male |
| Radhika Shah | Company Secretary & Compliance Officer | — | female |
| Shailee Chatrath Tyagi | Head of Functional Nutrition Portfolio | — | female |
| Srinandan Sundaram | CEO of Unilever International | — | male |
| Vibhav Ramrao Sanzgiri | Chief R&D Officer & Executive Director of R&D | — | — |
| Vivek Mittal | Executive Director of Legal & Corporate Affairs | — | — |
| Yogesh Kumar Mishra | Executive Director of Supply Chain | — | male |
| Yogesh Mulgaonkar | Head of Investor Relations & Head of Finance, Personal Care | — | male |
| Niranjan Kumar Gupta | Chief Financial Officer & Executive Director of Finance | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HINDUNILVR.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
